How Hider was paid
$29.8M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|
| Andrew HiderPresident and CEO | $499,315 | $1,000,000 | $23,133,518 | $3,185,053 | $820,125 | $1,167,171 | $29,805,182 |
| José E. AlmeidaFormer Chair of the Board, President and CEO | $660,420 | — | — | — | — | $7,005,624 | $7,666,044 |
| Brent ShaferNon-Executive Chair and Former Executive Chair and Interim CEO | $701,644 | $654,839 | $2,400,815 | — | — | $52,695 | $3,809,993 |
| Joel GradeFormer Executive Vice President and CFO | $827,825 | — | $5,809,671 | $1,049,372 | $459,000 | $63,700 | $8,209,568 |
| Heather KnightFormer Executive Vice President, COO and Interim Group President | $747,123 | — | $4,018,281 | $1,267,349 | — | $41,795 | $6,074,548 |
| Reazur RasulExecutive Vice President and Group President, Healthcare Systems & Technologies | $800,000 | — | $2,953,421 | $931,507 | $488,000 | $73,286 | $5,246,214 |
| David RosenbloomExecutive Vice President and General Counsel | $760,000 | — | $1,989,036 | $627,345 | $348,840 | $68,943 | $3,794,164 |
| Alok SonigFormer Executive Vice President and Group President, Pharmaceuticals | $779,747 | — | $3,375,371 | $1,064,578 | — | $19,577 | $5,239,273 |
What changed and why
- Andrew Hider joined Baxter as president and CEO in late August 2025.
- $29.8MAndrew Hider received total compensation of $29,805,182 for fiscal 2025 including sign-on awards.
- $6.9MJosé E. Almeida received a lump-sum termination payment equal to $6,890,000 in connection with his separation.
- 91%Stockholders approved the prior year executive compensation program with approximately 91% support.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.